Six months ago, in September 2017, I reported a $100 million joint venture announcement between Bayer and Ginkgo Bioworks that aimed to engineer nitrogen-fixing microbes, which could be put into seed coatings and provide nutrients to non-legume crops. Now, the joint venture has been named, and Joyn Bio is staffing up. For the ammonia industry, this represents potential demand destruction at a significant scale in the coming decades.
The Joyn Bio team is currently characterizing Bayer’s extensive library of more than 100,000 proprietary microbial strains using the high-throughput advanced analytics of Ginkgo’s foundries. The unprecedented scale of biological data generated using the sophisticated foundry tools is enabling Joyn Bio to identify the strains and characteristics necessary to further develop nitrogen fixing bacteria for sustainable agriculture.
Joyn Bio: Bayer and Ginkgo Bioworks Unveil Joint Venture, Joyn Bio, and Establish Operations in Boston and West Sacramento, 03/20/2018
Read the full article at AmmoniaIndustry.com